Insider Trading & Ownership - Prener Anne

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Prener Anne

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-20
Option Award
2024-06-21
4:00 pm
N/A
2034-06-19
Galecto Inc.GLTOPrener Anne
Director
18,000$018,000
(Direct)
View
2023-06-14
Option Award
2023-06-15
4:00 pm
N/A
2033-06-13
Galecto Inc.GLTOPrener Anne
Director
18,000$018,000
(Direct)
View
2022-06-14
Option Award
2022-06-15
4:00 pm
N/A
2032-06-13
Galecto Inc.GLTOPrener Anne
Director
18,000$018,000
(Direct)
View
2022-05-12
Option Award
2022-05-13
4:35 pm
N/A
2032-05-11
Rubius Therapeutics Inc.RUBYPrener Anne
Director
25,000$025,000
(Direct)
View
2021-06-30
Option Award
2021-07-01
4:28 pm
2022-06-30
2031-06-29
Kaleido Biosciences Inc.KLDOPrener Anne
Director
15,000$015,000
(Direct)
View
2021-05-26
Option Award
2021-05-28
4:00 pm
N/A
2031-05-25
Galecto Inc.GLTOPrener Anne
Director
18,000$018,000
(Direct)
View
2021-05-12
Option Award
2021-05-13
8:34 pm
N/A
2031-05-11
Rubius Therapeutics Inc.RUBYPrener Anne
Director
25,000$025,000
(Direct)
View
2021-01-08
Option Award
2021-01-08
4:01 pm
N/A
2031-01-08
Galecto Inc.GLTOPrener Anne
Director
24,000$024,000
(Direct)
View
2020-06-30
Option Award
2020-07-01
4:16 pm
2021-06-30
2030-06-29
Kaleido Biosciences Inc.KLDOPrener Anne
Director
15,000$015,000
(Direct)
View
2020-04-01
Option Award
2020-04-03
08:57 am
N/A
2030-04-01
Kaleido Biosciences Inc.KLDOPrener Anne
Director
30,000$030,000
(Direct)
View
2019-12-31
Option Award
2020-01-03
2:55 pm
N/A
2029-12-30
Rubius Therapeutics Inc.RUBYPrener Anne
Director
50,000$050,000
(Direct)
View